297 related articles for article (PubMed ID: 25652327)
41. Characterization of a novel founder MSH6 mutation causing Lynch syndrome in the French Canadian population.
Castellsagué E; Liu J; Volenik A; Giroux S; Gagné R; Maranda B; Roussel-Jobin A; Latreille J; Laframboise R; Palma L; Kasprzak L; Marcus VA; Breguet M; Nolet S; El-Haffaf Z; Australie K; Gologan A; Aleynikova O; Oros-Klein K; Greenwood C; Mes-Masson AM; Provencher D; Tischkowitz M; Chong G; Rousseau F; Foulkes WD
Clin Genet; 2015 Jun; 87(6):536-42. PubMed ID: 25318681
[TBL] [Abstract][Full Text] [Related]
42. Is surveillance of the small bowel indicated for Lynch syndrome families?
ten Kate GL; Kleibeuker JH; Nagengast FM; Craanen M; Cats A; Menko FH; Vasen HF
Gut; 2007 Sep; 56(9):1198-201. PubMed ID: 17409122
[TBL] [Abstract][Full Text] [Related]
43. Lynch syndrome: a pediatric perspective.
Huang SC; Durno CA; Erdman SH
J Pediatr Gastroenterol Nutr; 2014 Feb; 58(2):144-52. PubMed ID: 24051481
[TBL] [Abstract][Full Text] [Related]
44. Long-term psychosocial and behavioral adjustment in individuals receiving genetic test results in Lynch syndrome.
Esplen MJ; Wong J; Aronson M; Butler K; Rothenmund H; Semotiuk K; Madlensky L; Way C; Dicks E; Green J; Gallinger S
Clin Genet; 2015 Jun; 87(6):525-32. PubMed ID: 25297893
[TBL] [Abstract][Full Text] [Related]
45. Cancer screening behaviors and risk perceptions among family members of colorectal cancer patients with unexplained mismatch repair deficiency.
Katz LH; Advani S; Burton-Chase AM; Fellman B; Polivka KM; Yuan Y; Lynch PM; Peterson SK
Fam Cancer; 2017 Apr; 16(2):231-237. PubMed ID: 27832499
[TBL] [Abstract][Full Text] [Related]
46. Identification and management of Lynch syndrome in the Middle East and North African countries: outcome of a survey in 12 countries.
Sina M; Ghorbanoghli Z; Abedrabbo A; Al-Mulla F; Sghaier RB; Buisine MP; Cortas G; Goshayeshi L; Hadjisavvas A; Hammoudeh W; Hamoudi W; Jabari C; Loizidou MA; Majidzadeh-A K; Marafie MJ; Muslumov G; Rifai L; Seir RA; Talaat SM; Tunca B; Ziada-Bouchaar H; Velthuizen ME; Sharara AI; Ahadova A; Georgiou D; Vasen HFA;
Fam Cancer; 2021 Jul; 20(3):215-221. PubMed ID: 33098072
[TBL] [Abstract][Full Text] [Related]
47. Increasing Lynch syndrome identification through establishment of a hereditary colorectal cancer registry.
Sturgeon D; McCutcheon T; Geiger TM; Muldoon RL; Herline AJ; Wise PE
Dis Colon Rectum; 2013 Mar; 56(3):308-14. PubMed ID: 23392144
[TBL] [Abstract][Full Text] [Related]
48. Genetic testing for Lynch syndrome: family communication and motivation.
Leenen CH; Heijer Md; van der Meer C; Kuipers EJ; van Leerdam ME; Wagner A
Fam Cancer; 2016 Jan; 15(1):63-73. PubMed ID: 26446592
[TBL] [Abstract][Full Text] [Related]
49. Universal Screening of Colorectal Cancers for Lynch Syndrome: Challenges and Opportunities.
Vindigni SM; Kaz AM
Dig Dis Sci; 2016 Apr; 61(4):969-76. PubMed ID: 26602911
[TBL] [Abstract][Full Text] [Related]
50. Stakeholder Perspectives on Overcoming Barriers to Cascade Testing in Lynch Syndrome: A Qualitative Study.
Srinivasan S; Hampel H; Leeman J; Patel A; Kulchak Rahm A; Reuland DS; Roberts MC
Cancer Prev Res (Phila); 2020 Dec; 13(12):1037-1046. PubMed ID: 32727822
[TBL] [Abstract][Full Text] [Related]
51. Deficient mismatch repair testing in colorectal cancer: more than just screening for Lynch syndrome.
West NP
Colorectal Dis; 2019 Jun; 21(6):621-622. PubMed ID: 31152577
[No Abstract] [Full Text] [Related]
52. A Prospective Six Sigma Quality Improvement Trial to Optimize Universal Screening for Genetic Syndrome Among Patients With Young-Onset Colorectal Cancer.
Dineen S; Lynch PM; Rodriguez-Bigas MA; Bannon S; Taggart M; Reeves C; Modaro C; Overman M; Chang GJ; Skibber JM; You YN
J Natl Compr Canc Netw; 2015 Jul; 13(7):865-72. PubMed ID: 26150580
[TBL] [Abstract][Full Text] [Related]
53. Psychosocial consequences of predictive genetic testing for Lynch syndrome and associations to surveillance behaviour in a 7-year follow-up study.
Aktan-Collan K; Kääriäinen H; Järvinen H; Peltomäki P; Pylvänäinen K; Mecklin JP; Haukkala A
Fam Cancer; 2013 Dec; 12(4):639-46. PubMed ID: 23512527
[TBL] [Abstract][Full Text] [Related]
54. Molecular screening of all colorectal tumors diagnosed before age 50 years followed by genetic testing efficiently identifies Lynch syndrome cases.
Jenkins MA; Dowty JG; Hopper JL; Southey MC
Int J Cancer; 2009 Mar; 124(5):x-i. PubMed ID: 19097168
[No Abstract] [Full Text] [Related]
55. Patterns of germline and somatic testing after universal tumor screening for Lynch syndrome: A clinical practice survey of active members of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer.
Hodan R; Rodgers-Fouche L; Arora S; Dominguez-Valentin M; Kanth P; Katona BW; Mraz KA; Roberts ME; Vilar E; Soto-Azghani CM; Brand RE; Esplin ED; Perez K
J Genet Couns; 2022 Aug; 31(4):949-955. PubMed ID: 35218578
[TBL] [Abstract][Full Text] [Related]
56. Changes in screening behaviors and attitudes toward screening from pre-test genetic counseling to post-disclosure in Lynch syndrome families.
Burton-Chase AM; Hovick SR; Peterson SK; Marani SK; Vernon SW; Amos CI; Frazier ML; Lynch PM; Gritz ER
Clin Genet; 2013 Mar; 83(3):215-20. PubMed ID: 23414081
[TBL] [Abstract][Full Text] [Related]
57. Attitudes toward childbearing and prenatal testing in individuals undergoing genetic testing for Lynch syndrome.
Dewanwala A; Chittenden A; Rosenblatt M; Mercado R; Garber JE; Syngal S; Stoffel EM
Fam Cancer; 2011 Sep; 10(3):549-56. PubMed ID: 21567236
[TBL] [Abstract][Full Text] [Related]
58. A new hereditary colorectal cancer network in the Middle East and eastern mediterranean countries to improve care for high-risk families.
Ghorbanoghli Z; Jabari C; Sweidan W; Hammoudeh W; Cortas G; Sharara AI; Abedrabbo A; Hourani I; Mahjoubi B; Majidzadeh K; Tözün N; Ziada-Bouchaar H; Hamoudi W; Diab O; Khorshid HRK; Lynch H; Vasen H
Fam Cancer; 2018 Apr; 17(2):209-212. PubMed ID: 28685475
[TBL] [Abstract][Full Text] [Related]
59. Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome.
Yurgelun MB; Mercado R; Rosenblatt M; Dandapani M; Kohlmann W; Conrad P; Blanco A; Shannon KM; Chung DC; Terdiman J; Gruber SB; Garber JE; Syngal S; Stoffel EM
Gynecol Oncol; 2012 Dec; 127(3):544-51. PubMed ID: 22940489
[TBL] [Abstract][Full Text] [Related]
60. Cost-effectiveness of Active Identification and Subsequent Colonoscopy Surveillance of Lynch Syndrome Cases.
Peterse EFP; Naber SK; Daly C; Pollett A; Paszat LF; Spaander MCW; Aronson M; Gryfe R; Rabeneck L; Lansdorp-Vogelaar I; Baxter NN
Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2760-2767.e12. PubMed ID: 31629885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
